Preferred Label : Rubinstein-taybi syndrome 2;
Symbol : RSTS2;
CISMeF acronym : RSTS2;
Type : Phenotype, molecular basis known;
Description : Rubinstein-Taybi syndrome (RSTS) is a multiple congenital anomaly syndrome characterized
by mental retardation, postnatal growth deficiency, microcephaly, broad thumbs and
halluces, and dysmorphic facial features. The classic facial appearance is striking,
with highly arched eyebrows, long eyelashes, downslanting palpebral fissures, broad
nasal bridge, beaked nose with the nasal septum, highly arched palate, mild micrognathia,
and characteristic grimacing or abnormal smile (Rubinstein and Taybi, 1963; review
by Hennekam, 2006). About 50 to 70% of patients have RSTS1 due to mutation in the
CREBBP gene (600140). RSTS2 is much less common, and about 3% of patients have mutations
in the EP300 gene. RSTS2 appears to be associated with a milder phenotype than RSTS1.
Patients with RSTS2 have less severe facial dysmorphism and better cognitive function,
but may have more severe microcephaly and malformation of facial bone structures compared
to those with RSTS1 (Bartsch et al., 2010).;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the 300-KD E1A-binding protein gene (EP300, 602700.0003);
Prefixed ID : #613684;
Origin ID : 613684;
UMLS CUI : C3150941;
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT